Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of age and self-stigmatization on social eating and drinking issues in French outpatients living with and beyond head and neck cancer: a mixed-method study.
Beauplet B, Francois B, Bastit V, Lequesne J, Rambeau A, Basti S, Gery B, Larnaudie A, Lasne-Cardon A, Roussel LM, Veresezan O, Jean CP, Chatelier A, Ambroise B, Veyssiere A, Bellefqih S, Thureau S, Levitchi M, Obongo-Anga FR, Babin E, Dornan M, Mange J, Humbert M. Beauplet B, et al. Among authors: thureau s. Support Care Cancer. 2024 Sep 13;32(10):659. doi: 10.1007/s00520-024-08859-8. Support Care Cancer. 2024. PMID: 39271541
Benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers.
Bastit V, Bon-Mardion N, Picquenot JM, Rainville V, Moldovan C, François A, Loeb A, Thureau S, Manu D, Jardin F, Marie JP, Di Fiore F, Clatot F. Bastit V, et al. Among authors: thureau s. Eur Arch Otorhinolaryngol. 2019 Feb;276(2):541-550. doi: 10.1007/s00405-018-5235-6. Epub 2018 Dec 6. Eur Arch Otorhinolaryngol. 2019. PMID: 30523411
Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up].
Vera P, Mihailescu SD, Lequesne J, Modzelewski R, Bohn P, Hapdey S, Pépin LF, Dubray B, Chaumet-Riffaud P, Decazes P, Thureau S; all investigators of RTEP5 study (list in annexe). Vera P, et al. Among authors: thureau s. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1448-1456. doi: 10.1007/s00259-019-04285-9. Epub 2019 Mar 13. Eur J Nucl Med Mol Imaging. 2019. PMID: 30868230 Clinical Trial.
[PET technology: Latest advances and potential impact on radiotherapy].
Decazes P, Hapdey S, Larnaudie A, Thariat J, Thureau S. Decazes P, et al. Among authors: thureau s. Cancer Radiother. 2020 Oct;24(6-7):628-634. doi: 10.1016/j.canrad.2020.07.006. Epub 2020 Aug 27. Cancer Radiother. 2020. PMID: 32861609 Review. French.
Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review.
Decazes P, Hinault P, Veresezan O, Thureau S, Gouel P, Vera P. Decazes P, et al. Among authors: thureau s. Front Oncol. 2021 Feb 4;10:614008. doi: 10.3389/fonc.2020.614008. eCollection 2020. Front Oncol. 2021. PMID: 33614497 Free PMC article. Review.
121 results